EBV-gp350 Confers B-Cell Tropism to Tailored Exosomes and Is a Neo-Antigen in Normal and Malignant B Cells—A New Option for the Treatment of B-CLL

Exosomes Containing Glycoprotein 350 Released by EBV-Transformed B Cells Selectively Target B Cells through CD21 and Block EBV Infection In Vitro

(2010) H. Vallhov et al.   JOURNAL OF IMMUNOLOGY

Relative seroprevalence of human herpes viruses in patients with chronic lymphocytic leukaemia

(2009) C. Steininger et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Exosomes are an effective vaccine against congenital toxoplasmosis in mice

(2009) Céline Beauvillain et al.   VACCINE

A Polyvalent Cellular Vaccine Induces T-cell Responses Against Specific Self-antigens Overexpressed in Chronic Lymphocytic B-cell Leukemia

(2008) Konrad Kronenberger et al.   JOURNAL OF IMMUNOTHERAPY

Standardized and Highly Efficient Expansion of Epstein-Barr Virus-Specific CD4+ T Cells by Using Virus-Like Particles

(2008) D. Adhikary et al.   JOURNAL OF VIROLOGY

Conditional Immortalization of Human B Cells by CD40 Ligation

(2008) Martina Wiesner et al.   PLoS One